Teva Unit Takes Aim At Lilly In Chemo Patent Battle
In the latest move in a four-month long patent feud, Sicor Pharmaceuticals Inc., a unit of Teva Pharmaceuticals, is taking aim at Eli Lilly & Co. in federal court, seeking declaratory...To view the full article, register now.
Already a subscriber? Click here to view full article